Delirium Clinical Trials

Find Delirium Clinical Trials Near You

Effect of Pericapsular Nerve Group (PENG) Block Added to Spinal Anesthesia on Postoperative Delirium in Older Adults Undergoing Primary Total Hip Arthroplasty: A Prospective, Randomized, Assessor-Blinded Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Postoperative delirium is a common and serious complication in older adults undergoing total hip arthroplasty, associated with prolonged hospitalization, increased morbidity, delayed rehabilitation, and long-term cognitive decline. Modifiable perioperative risk factors include uncontrolled postoperative pain, opioid consumption, impaired early mobilization, and systemic inflammatory response. The Pericapsular Nerve Group (PENG) block is a regional anesthesia technique targeting the sensory innervation of the anterior hip capsule and may provide effective analgesia while preserving motor function. Improved pain control and opioid reduction may decrease the incidence of postoperative delirium. This prospective, randomized, parallel-group controlled trial aims to evaluate whether the addition of ultrasound-guided PENG block to spinal anesthesia reduces the incidence of postoperative delirium within 72 hours after primary total hip arthroplasty in patients aged 65 years or older. Delirium will be assessed using the Confusion Assessment Method (CAM) by blinded outcome assessors. Secondary outcomes include postoperative opioid consumption, pain intensity (NRS), time to first rescue opioid, postoperative nausea and vomiting, time to mobilization, block-related adverse events, and perioperative inflammatory indices (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio). The study will enroll 144 patients randomized 1:1 to spinal anesthesia alone or spinal anesthesia plus PENG block.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 75
Maximum Age: 100
Healthy Volunteers: f
View:

• Age ≥ 75 years

• Scheduled for elective primary total hip arthroplasty

• Planned spinal anesthesia

• ASA physical status II-III

• Ability to provide written informed consent

• Ability to communicate and reliably assess pain using the Numeric Rating Scale (NRS)

• Expected postoperative hospitalization ≥ 72 hours

Locations
Other Locations
Poland
Poznan University of Medical Sciences
RECRUITING
Poznan
Contact Information
Primary
Malgorzata Reysner, MD PhD
mreysner@ump.edu.pl
+48 61 8320122
Backup
Malgorzata Reysner, MD PhD
mreysner@ump.edu.pl
+48 501056924
Time Frame
Start Date: 2026-03-01
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 180
Treatments
Placebo_comparator: Sham Block
PENG block with 20ml of 0.9% sodium chloride
Active_comparator: PENG block
PENG block with 20ml 0f 0.2% ropivacaine
Sponsors
Leads: Poznan University of Medical Sciences

This content was sourced from clinicaltrials.gov